Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Benzer

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
British Journal of Anaesthesia|February 21, 2003
Remifentanil and nitrous oxide reduce changes in cerebral blood flow velocity in the middle cerebral artery caused by painI H Lorenz, C Kolbitsch, M Hinteregger, et al.
Neuroscience|December 1, 1994
Molecular characterization of immunoreactivities of peptides derived from chromogranin A (GE-25) and from secretogranin II (secretoneurin) in human and bovine cerebrospinal fluidR Kirchmair, A Benzer, J Troger, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|September 24, 2025
Impact of a multifaceted intervention including supportive care order sentence implementation on outpatient antibiotic prescribing for upper respiratory tract infectionsAshlyn M Kiebach, Lauren R Stonerock, Tara E McAlpine, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 20, 1998
Levels and proteolytic processing of chromogranin A and B and secretogranin II in cerebrospinal fluid in neurological diseasesU Eder, B Leitner, R Kirchmair, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
British Journal of Anaesthesia|February 21, 2003
Remifentanil and nitrous oxide reduce changes in cerebral blood flow velocity in the middle cerebral artery caused by painI H Lorenz, C Kolbitsch, M Hinteregger, et al.
Neuroscience|December 1, 1994
Molecular characterization of immunoreactivities of peptides derived from chromogranin A (GE-25) and from secretogranin II (secretoneurin) in human and bovine cerebrospinal fluidR Kirchmair, A Benzer, J Troger, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|September 24, 2025
Impact of a multifaceted intervention including supportive care order sentence implementation on outpatient antibiotic prescribing for upper respiratory tract infectionsAshlyn M Kiebach, Lauren R Stonerock, Tara E McAlpine, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 20, 1998
Levels and proteolytic processing of chromogranin A and B and secretogranin II in cerebrospinal fluid in neurological diseasesU Eder, B Leitner, R Kirchmair, et al.
Pageof 9